Microbiome, Immunomodulation, and the Neuronal System

Eric Marietta, Irina Horwath, Veena D Taneja

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Vertebrates harbor both symbiotic and pathogenic bacteria on the body and various mucosal surfaces. Of these surfaces, the intestine has the most diverse composition. This composition is dependent upon various environmental and genetic factors, with diet exerting the maximum influence. Significant roles of the intestinal bacteria are to stimulate the development of a competent mucosal immune system and to maintain tolerance within the intestine. One manner in which this is achieved is by the establishment of epithelial integrity by microbiota found in healthy individuals (healthy microbiota); however, in the case of a disrupted intestinal microbiome (dysbiosis), which can be caused by various conditions, the epithelial integrity is compromised. This decreased epithelial integrity can then lead to luminal products crossing the barrier, generating a systemic proinflammatory response. In addition to epithelial integrity, healthy intestinal commensals metabolize indigestible dietary substrates and produce short-chain fatty acids, which are bacterial metabolites that are essential for colonic health and regulating the function of the intestinal immune system. Intestinal commensals are also capable of producing neuroactive molecules and neurotransmitters that can affect the function of the vagus nerve. The observations that intestinal dysbiosis is associated with different diseases of the nervous system, suggests that cross-talk occurs amongst the gut, the nervous system, and the immune system.

Original languageEnglish (US)
Pages (from-to)23-30
Number of pages8
JournalNeurotherapeutics
Volume15
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Immunomodulation
Microbiota
Dysbiosis
Immune System
Intestines
Bacteria
Vagus Nerve
Volatile Fatty Acids
Nervous System Diseases
Nervous System
Neurotransmitter Agents
Vertebrates
Diet
Health

Keywords

  • Dysbiosis
  • Immunomodulation
  • Intestinal
  • Microbiome
  • Neuronal

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Neurology
  • Pharmacology (medical)

Cite this

Microbiome, Immunomodulation, and the Neuronal System. / Marietta, Eric; Horwath, Irina; Taneja, Veena D.

In: Neurotherapeutics, Vol. 15, No. 1, 01.01.2018, p. 23-30.

Research output: Contribution to journalReview article

Marietta, Eric ; Horwath, Irina ; Taneja, Veena D. / Microbiome, Immunomodulation, and the Neuronal System. In: Neurotherapeutics. 2018 ; Vol. 15, No. 1. pp. 23-30.
@article{ee455cbaec0b42e0a1eb4e5de5c33fd8,
title = "Microbiome, Immunomodulation, and the Neuronal System",
abstract = "Vertebrates harbor both symbiotic and pathogenic bacteria on the body and various mucosal surfaces. Of these surfaces, the intestine has the most diverse composition. This composition is dependent upon various environmental and genetic factors, with diet exerting the maximum influence. Significant roles of the intestinal bacteria are to stimulate the development of a competent mucosal immune system and to maintain tolerance within the intestine. One manner in which this is achieved is by the establishment of epithelial integrity by microbiota found in healthy individuals (healthy microbiota); however, in the case of a disrupted intestinal microbiome (dysbiosis), which can be caused by various conditions, the epithelial integrity is compromised. This decreased epithelial integrity can then lead to luminal products crossing the barrier, generating a systemic proinflammatory response. In addition to epithelial integrity, healthy intestinal commensals metabolize indigestible dietary substrates and produce short-chain fatty acids, which are bacterial metabolites that are essential for colonic health and regulating the function of the intestinal immune system. Intestinal commensals are also capable of producing neuroactive molecules and neurotransmitters that can affect the function of the vagus nerve. The observations that intestinal dysbiosis is associated with different diseases of the nervous system, suggests that cross-talk occurs amongst the gut, the nervous system, and the immune system.",
keywords = "Dysbiosis, Immunomodulation, Intestinal, Microbiome, Neuronal",
author = "Eric Marietta and Irina Horwath and Taneja, {Veena D}",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/s13311-017-0601-4",
language = "English (US)",
volume = "15",
pages = "23--30",
journal = "Neurotherapeutics",
issn = "1933-7213",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Microbiome, Immunomodulation, and the Neuronal System

AU - Marietta, Eric

AU - Horwath, Irina

AU - Taneja, Veena D

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Vertebrates harbor both symbiotic and pathogenic bacteria on the body and various mucosal surfaces. Of these surfaces, the intestine has the most diverse composition. This composition is dependent upon various environmental and genetic factors, with diet exerting the maximum influence. Significant roles of the intestinal bacteria are to stimulate the development of a competent mucosal immune system and to maintain tolerance within the intestine. One manner in which this is achieved is by the establishment of epithelial integrity by microbiota found in healthy individuals (healthy microbiota); however, in the case of a disrupted intestinal microbiome (dysbiosis), which can be caused by various conditions, the epithelial integrity is compromised. This decreased epithelial integrity can then lead to luminal products crossing the barrier, generating a systemic proinflammatory response. In addition to epithelial integrity, healthy intestinal commensals metabolize indigestible dietary substrates and produce short-chain fatty acids, which are bacterial metabolites that are essential for colonic health and regulating the function of the intestinal immune system. Intestinal commensals are also capable of producing neuroactive molecules and neurotransmitters that can affect the function of the vagus nerve. The observations that intestinal dysbiosis is associated with different diseases of the nervous system, suggests that cross-talk occurs amongst the gut, the nervous system, and the immune system.

AB - Vertebrates harbor both symbiotic and pathogenic bacteria on the body and various mucosal surfaces. Of these surfaces, the intestine has the most diverse composition. This composition is dependent upon various environmental and genetic factors, with diet exerting the maximum influence. Significant roles of the intestinal bacteria are to stimulate the development of a competent mucosal immune system and to maintain tolerance within the intestine. One manner in which this is achieved is by the establishment of epithelial integrity by microbiota found in healthy individuals (healthy microbiota); however, in the case of a disrupted intestinal microbiome (dysbiosis), which can be caused by various conditions, the epithelial integrity is compromised. This decreased epithelial integrity can then lead to luminal products crossing the barrier, generating a systemic proinflammatory response. In addition to epithelial integrity, healthy intestinal commensals metabolize indigestible dietary substrates and produce short-chain fatty acids, which are bacterial metabolites that are essential for colonic health and regulating the function of the intestinal immune system. Intestinal commensals are also capable of producing neuroactive molecules and neurotransmitters that can affect the function of the vagus nerve. The observations that intestinal dysbiosis is associated with different diseases of the nervous system, suggests that cross-talk occurs amongst the gut, the nervous system, and the immune system.

KW - Dysbiosis

KW - Immunomodulation

KW - Intestinal

KW - Microbiome

KW - Neuronal

UR - http://www.scopus.com/inward/record.url?scp=85041456207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041456207&partnerID=8YFLogxK

U2 - 10.1007/s13311-017-0601-4

DO - 10.1007/s13311-017-0601-4

M3 - Review article

C2 - 29313275

AN - SCOPUS:85041456207

VL - 15

SP - 23

EP - 30

JO - Neurotherapeutics

JF - Neurotherapeutics

SN - 1933-7213

IS - 1

ER -